211 publications
Room for improvement analysis: Peripheral Arterial Disease – Zinnige Zorg
This Room for Improvement Analysis describes the research and the resulting actions and agreements that focus on further...
Teduglutide (Revestive®) for the treatment of short bowel syndrome
The Minister of Health, Welfare and Sport (VWS) has asked Zorginstituut Nederland to carry out an assessment of teduglutide...
Organisation structure National Health Care Institute
Dimethyl fumarate (Skilarence®) for the treatment of plaque psoriasis in adults
The Minister of Health, Welfare and Sport (WVS) asked Zorginstituut Nederland (National Health Care Institute) to carry out an...
Flash Glucose Monitoring (FGM)
In this report Zorginstituut Nederland (National Health Care Institute) assesses whether Flash Glucose Monitoring (FGM)...
Rolapitant (Varuby®) for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults
Zorginstituut Nederland has carried out an assessment of the medicinal product rolapitant (Varuby®). The GVS report concludes...
Belimumab (Benlysta®) for the treatment of adult patients with auto-antibody-positive systemic lupus erythematosus (SLE)
Zorginstituut Nederland has carried out an assessment of the medicinal product subcutaneous belimumab (Benlysta®) and a...
Fampridine (Fampyra®) in cases of multiple sclerosis (MS)
Zorginstituut Nederland carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the outcomes of the...
Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia
Zorginstituut Nederland issued package advice on the medicinal product evolocumab (Repatha®) for the treatment of...
Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis
Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL...